Insider plans sale of 8,864 CMA shares

An affiliated holder of CMA common stock has filed a Rule 144 notice to sell 8,864 shares through Fidelity Brokerage Services LLC on or about 01/27/2026 on the NYSE, with an indicated aggregate market value of $837,352.99.

Accepted by SEC EDGAR 01/27/2026 - 11:40 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An affiliated holder of CMA common stock has filed a Rule 144 notice to sell 8,864 shares through Fidelity Brokerage Services LLC on or about 01/27/2026 on the NYSE, with an indicated aggregate market value of $837,352.99. The filing states that 127,742,643 common shares were outstanding.

The shares to be sold were acquired from the issuer through a mix of stock options exercised, employee stock purchase plan (ESPP) purchases, and restricted stock vesting between 06/30/2025 and 01/27/2026, paid either in cash or as compensation. The person on whose behalf the sale is planned represents that they are not aware of any undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CMA Form 144 filing disclose?

It discloses that a holder of CMA common stock intends to sell 8,864 shares on the NYSE through Fidelity Brokerage Services LLC under Rule 144.

What is the aggregate market value of the CMA shares to be sold?

The Form 144 states an aggregate market value of $837,352.99 for the 8,864 CMA common shares planned for sale.

How many CMA shares were outstanding according to this notice?

The notice reports that there were 127,742,643 common shares outstanding of the issuer at the time referenced.

When are the CMA shares expected to be sold under this Form 144?

The filing lists an approximate date of sale of 01/27/2026 for the 8,864 CMA common shares to be sold on the NYSE.

How were the CMA shares to be sold under Rule 144 acquired?

They were acquired from the issuer through stock option grants, ESPP purchases, and restricted stock vesting between 06/30/2025 and 01/27/2026, using either cash or compensation.

Does the CMA Form 144 include any representation about insider information?

Yes. The person for whose account the shares are to be sold represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001988003
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COMERICA INC
SEC File Number	001-10706
Address of Issuer	1717 MAIN STREET MC6404 ATTN: KELLY GAGE DALLAS TEXAS 75201
Phone	833-571-0486
Name of Person for Whose Account the Securities are To Be Sold	Fleming Allysun C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8864	837352.99	127742643	01/27/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2026	Option Granted 01/24/2023	Issuer			1646	01/27/2026	Cash
Common	01/27/2026	Option Granted 01/23/2024	Issuer			1342	01/27/2026	Cash
Common	06/30/2025	ESPP Purchase	Issuer			44	06/30/2025	Cash
Common	08/31/2025	Restricted Stock Vesting	Issuer			2119	08/31/2025	Compensation
Common	09/30/2025	ESPP Purchase	Issuer			75	09/30/2025	Cash
Common	12/29/2025	Restricted Stock Vesting	Issuer			1086	12/29/2025	Compensation
Common	12/31/2025	ESPP Purchase	Issuer			49	12/31/2025	Cash
Common	01/15/2026	Restricted Stock Vesting	Issuer			2503	01/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Allysun C. Fleming
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)